Levothyroxine treats hypothyroidism (low thyroid hormone). Ischemic heart disease and significant effects on cardiac function including an increased incidence of premature ventricular beats, an increased left ventricular mass index, and synthroid delayed puberty left ventricular systolic function have been reported in clinical trials. Foods that contain soybean flour (including infant formula), cottonseed meal, walnuts, or dietary fiber may decrease the absorption of Synthroid. Tell your doctor if your diet includes any of these foods.
synthroid and estrogen
6 Product Characteristics Color ORANGE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;25 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4341-13 100 TABLET In 1 BOTTLE None 2 0074-4341-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4552 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 50 ug Inactive Ingredients Ingredient synthroid delayed puberty Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC Product Characteristics Color WHITE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;50 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4552-13 100 TABLET In 1 BOTTLE None 2 0074-4552-19 1000 TABLET In 1 BOTTLE None 3 0074-4552-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 3 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-4552-11) 4 0074-4552-71 28 TABLET In 1 BOX None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-5182 Route of Administration synthroid delayed puberty DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 75 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE synthroid delayed puberty MAGNESIUM STEARATE POVIDONE TALC FD&C RED NO. The Synthroid tablet can dissolve very quickly and swell in the throat, possibly causing choking or gagging. In patients treated with synthroid delayed puberty doses of synthroid delayed puberty (> 160 mg/day), T3 and T4 levels change slightly, TSH levels remain normal, and patients are clinically euthyroid. 1 Aluminum Lake 150 FD&C Blue No. Synthroid is used for: Treating low thyroid hormone levels and certain types of goiters. Seek medical attention right away if any of these SEVERE side effects occur: Severe allergic reactions (rash; hives; itching; difficulty breathing; flushing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); changes in appetite; changes in menstrual periods; chest pain; diarrhea; excessive sweating; fast or irregular heartbeat; fever; heat intolerance; joint pain; leg cramps; mental or synthroid delayed puberty changes (eg, anxiety, irritability, nervousness); muscle weakness; seizures; severe or persistent headache or fatigue; shortness of breath; stomach cramps; tremors; trouble sleeping; unusual weight gain or weight loss; vomiting; wheezing. Thyroid hormones cross the placental barrier to some extent as evidenced by levels in cord blood of athyreotic fetuses being approximately one-third maternal levels. When serum T3 and T4 levels increase, TRH and TSH secretion decrease. To minimize the loss, the doctor will prescribe the lowest dosage needed to control symptoms of thyroid deficiency. In children with severe or prolonged hypothyroidism, catch-up growth may not be adequate to normalize adult height. Information for Patients Patients should be informed of the following information to aid in the synthroid delayed puberty and effective use of Synthroid: Notify your physician if you are allergic to any foods or medicines, are pregnant or intend to become pregnant, are breast-feeding or are taking any other medications, including prescription and over-the-counter preparations. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. Other Medical Problems The presence of other medical problems may affect the use of this medicine. Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). Levothyroxine is given when the thyroid does not produce enough of this hormone on its own. Tell your doctor if you have trouble swallowing. Patients with concomitant adrenal insufficiency should be treated with replacement glucocorticoids prior to initiation of treatment with levothyroxine sodium. Ask your pharmacist if you have any questions.
Generally, TSH is suppressed to < 0.1 mU/L, and this usually requires a levothyroxine sodium dose of greater than 2 mcg/kg/day. Patients with concomitant adrenal synthroid delayed puberty should be treated with replacement glucocorticoids prior to synthroid delayed puberty of treatment with levothyroxine sodium. See also: Synthroid dosage in more detail What happens if I miss a dose? Take the missed dose as soon as you remember. 40 Aluminum Lake, FD&C Blue No. Call your doctor for medical advice about side effects. Pseudotumor cerebri and slipped synthroid delayed puberty femoral epiphysis have been reported in children receiving levothyroxine therapy. Foods that decrease absorption of levothyroxine, such as soybean infant formula, should not be used for administering levothyroxine sodium tablets (see PRECAUTIONS - Drug-Food Interactions). Patients with coronary artery disease who are receiving levothyroxine therapy should be monitored closely during surgical procedures, since the possibility of precipitating cardiac arrhythmias may be greater in those treated with levothyroxine. Synthroid may be administered to infants and children who cannot swallow intact tablets by crushing the tablet and suspending the freshly crushed tablet in a small amount (5-10 mL or 1-2 teaspoons) of water. The drug is absorbed better on an empty stomach. Musculoskeletal Musculoskeletal side effects have included an increase risk of osteoporosis. This includes prescription, over-the-counter, vitamin, and herbal products. This is usually temporary. Seizures have been reported rarely with the institution of levothyroxine therapy.